Skip to main content

Promacta (eltrombopag) 12.5 mg for Oral Suspension, Rx Only Manufactured by: Halo Pharmaceuticals, Inc. Whippany, New Jersey 07981 Distributed by: Novartis Pharmaceuticals Corporation East Hanover, NJ 07936 Product of Ireland, NDC 0078-0972-61.

Drug Recall

Official source record

Recall number
D-1309-2019
Event ID
82820
Classification
Class I
Status
Terminated
Recalling company
Novartis Pharmaceuticals Corp.
Reason for recall
Cross Contamination with Other Products: product is being recalled due to possible cross-contamination with peanut flour.
Report date
May 29, 2019
Recall initiation date
May 11, 2019
Termination date
November 28, 2023
Distribution pattern
Nationwide with in the United States

Drug product identifiers

Manufacturer
Novartis Pharmaceuticals Corporation
Brand name
PROMACTA
Generic name
ELTROMBOPAG OLAMINE
Substance name
ELTROMBOPAG OLAMINE
Product NDCs
0078-0684; 0078-0685; 0078-0686; 0078-0687; 0078-0697; 0078-0972
Package NDCs
0078-0684-15; 0078-0685-15; 0078-0686-15; 0078-0686-55; 0078-0687-15; 0078-0697-19; 0078-0697-23; 0078-0697-61; 0078-0972-19; 0078-0972-23; 0078-0972-61
Route
ORAL

Where this information comes from

View FDA enforcement record -- the specific openFDA drug enforcement record this summary was built from.

This record comes from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for details.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class I mean?

A situation in which there is a reasonable probability that use of or exposure to a product will cause serious adverse health consequences or death.

Is this recall still active?

According to the FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this medication?

Do not start, stop, or change any medication based on this page. Follow the instructions published by the FDA and the recalling company (see the source links below), and talk to your pharmacist or physician if you have questions about a specific medication.

Where can I find more official information?

The source links below, published by the FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

Official guidance and record verification

Public Health Trace does not provide medical advice. The information below identifies general guidance published by the responsible government agency. Review the current official notice before taking action.

How to interpret this historical record

This record is preserved as published by FDA, as of November 28, 2023.

Status as reported: Terminated.

This page does not imply a current danger or a current consumer instruction -- review the official source for the most current information.

View the official FDA source

Public Health Trace republishes official FDA drug recall information -- it is not affiliated with the FDA, does not verify or supplement what the source has published, and does not provide medical advice. Never start, stop, or change a medication based on this page. Always follow the guidance of your pharmacist or physician, and consult the official source links above for the most current information. Read the full medical disclaimer.

Reconnecting to the server…

We lost the connection to the server.

Your session has expired.